Skip to content
value.today
Total raised
$22 M
1 round on record
Latest round
$22 M
Aug 2016
First round on record
Aug 2016
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medicrea
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2016$22 MNo. 1$10 to $50 million

Medicrea: Raise no. 1, Aug 2016

Investors in this round

12 investors had bought by the notice of Aug 26, 2016: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
$1,300,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in France

People named in the notice

  • David Ryan · Executive Officer · Director of R&D and Product Development
  • Denys Sournac · Executive Officer, Director · Chief Executive Officer and Chairman of the Board
  • Fabrice Kilfiger · Executive Officer · Chief Financial Officer
  • Richard Kienzle · Executive Officer · Chief Commercial Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Raymond James (CRD 705) · New York, New YorkSold in all US states

Signed by Fabrice Kilfiger, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 26, 2016. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medicrea had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Aug 2016).

    SEC Form D (revenue range) · Aug 2016

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2016

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Medicrea is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medicrea
NameRoleNamed in
David RyanDirector of R&D and Product DevelopmentAug 2016
Denys SournacChief Executive Officer and Chairman of the BoardAug 2016
Fabrice KilfigerChief Financial OfficerAug 2016
Richard KienzleChief Commercial OfficerAug 2016
Denys SournacChief Executive Officer and Chairman of the BoardAug 2016